← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CREEKWOOD PHARMS · Approved 2020-03-23

Drug application

FDA Application #

ANDA213423

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

PREGABALIN

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CREEKWOOD PHARMS

Manufacturer

Creekwood Pharmaceuticals LLC

First approval

2020-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown